Andres Briseno
Directeur Financier/CFO chez IDEAYA BIOSCIENCES, INC.
Fortune : 947 387 $ au 30/04/2024
Profil
Andres Ruiz Briseno is currently the Senior VP, Head-Finance & Investor Relations at IDEAYA Biosciences, Inc. He previously worked as the Associate Director-Financial Planning & Analysis at Pharmacyclics LLC from 2013 to 2016.
Andres completed his undergraduate degree at San Jose State University in 2009.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IDEAYA BIOSCIENCES, INC.
0,03% | 31/03/2024 | 24 531 ( 0,03% ) | 947 387 $ | 30/04/2024 |
Postes actifs de Andres Briseno
| Sociétés | Poste | Début |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Directeur Financier/CFO | 01/07/2023 |
Anciens postes connus de Andres Briseno
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01/08/2016 |
Formation de Andres Briseno
| San Jose State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IDEAYA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |